CMS released the Medicare 2023 Part C & D Star Ratings Technical Notes on October 6, 2022, which can be read in full here. For your convenience, PQS has summarized the 2023 Medicare Part C & D Star Ratings Technical Notes, which includes general points and highlights, focused updates for medication-related Part D measures, performance trend graphs, and measure threshold charts.
2023 Star Ratings Technical Notes Summary
A few general points summarize that:
- Medicare Advantage with prescription drug (Part D) coverage (MAPD) contracts are rated on up to 38 unique quality and performance measures.
- MA-only contracts (without prescription drug coverage, or Part D) are rated on up to 28 measures.
- Stand-alone Part D (PDP) contracts are rated on up to 12 measures.
- The recently revised Controlling Blood Pressure (Part C) measure transitioned off the display page and into the 2023 Star Ratings as a new measure. This measure has a weight of 1 for 2023 and will increase to a triple weighted measure for 2024.
- Statin Use in Persons with Diabetes (Part D) measure updates have been implemented which will change this measure from a triple-weighted intermediate outcome measure to a process measure with a weight of 1.
The full list of general points can be found on page 2 of the PQS Summary of 2023 Medicare Part C and D Star Ratings Technical Notes.
The 2023 Star Ratings for Medicare Part C & D plans are displayed on the Medicare Plan Finder found at www.medicare.gov. As of October 15, 2022, Medicare beneficiaries can view these 2023 Star Ratings when selecting their MAPD or PDP for the 2023 benefit year as part of the Open Enrollment period which will continue through December 7, 2022.
